LP-013-09

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLP-013-09
Drug Alias NameLPO-1010CALP-01309LP-013-09
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionImmunosuppressantsHIV integrase inhibitorsAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaila Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaila Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsCataract

Other Information

ATC CodeN/A
Related LinksN/A